tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RVMD Stock Latest News

Revolution Medicines’ Q3 2025 Earnings Call Highlights
Company AnnouncementsRevolution Medicines’ Q3 2025 Earnings Call Highlights
2d ago
RVMD
Erasca price target raised to $6 from $4 at Stifel
PremiumThe Fly
Erasca price target raised to $6 from $4 at Stifel
2d ago
ERAS
RVMD
Revolution Medicines: Buy Rating Reaffirmed Amid Strategic Developments and Increased Price Target
PremiumRatings
Revolution Medicines: Buy Rating Reaffirmed Amid Strategic Developments and Increased Price Target
2d ago
RVMD
JPMorgan ups Revolution Medicines target, adds to Analyst Focus List
PremiumThe Fly
JPMorgan ups Revolution Medicines target, adds to Analyst Focus List
2d ago
RVMD
Revolution Medicines price target raised to $73 from $72 at H.C. Wainwright
PremiumThe Fly
Revolution Medicines price target raised to $73 from $72 at H.C. Wainwright
2d ago
RVMD
Revolution Medicines Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsRevolution Medicines Reports Q3 2025 Financial Results
2d ago
RVMD
Revolution Medicines: Strategic Advancements and Promising Pipeline in PDAC Treatment Justify Buy Rating
Premium
Ratings
Revolution Medicines: Strategic Advancements and Promising Pipeline in PDAC Treatment Justify Buy Rating
2d ago
RVMD
Revolution Medicines: Promising Growth Trajectory with Strong Financial Health and Strategic Advancements
Premium
Ratings
Revolution Medicines: Promising Growth Trajectory with Strong Financial Health and Strategic Advancements
2d ago
RVMD
Revolution Medicines reiterates FY25 GAAP net loss guidance
PremiumThe Fly
Revolution Medicines reiterates FY25 GAAP net loss guidance
3d ago
RVMD
Revolution Medicines reports Q3 EPS ($1.61), consensus ($1.41)
PremiumThe Fly
Revolution Medicines reports Q3 EPS ($1.61), consensus ($1.41)
3d ago
RVMD
Boeing upgraded, Charter downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Boeing upgraded, Charter downgraded: Wall Street’s top analyst calls
5d ago
BA
ALH
Revolution Medicines initiated with an Outperform at RBC Capital
PremiumThe Fly
Revolution Medicines initiated with an Outperform at RBC Capital
5d ago
RVMD
Revolution Medicines: Promising Oncology Leader with Strategic Advancements and Competitive Edge
PremiumRatingsRevolution Medicines: Promising Oncology Leader with Strategic Advancements and Competitive Edge
10d ago
RVMD
Revolution Medicines Advances RAS(ON) Inhibitor Study in Gastrointestinal Cancers
Premium
Company Announcements
Revolution Medicines Advances RAS(ON) Inhibitor Study in Gastrointestinal Cancers
12d ago
RVMD
Revolution Medicines Advances RAS(ON) Inhibitors in NSCLC Study
Premium
Company Announcements
Revolution Medicines Advances RAS(ON) Inhibitors in NSCLC Study
12d ago
RVMD
Revolution Medicines’ RASolve 301 Study: A Potential Game-Changer for NSCLC Treatment
PremiumCompany Announcements
Revolution Medicines’ RASolve 301 Study: A Potential Game-Changer for NSCLC Treatment
12d ago
RVMD
Revolution Medicines Advances Phase 3 Trial for Pancreatic Cancer Treatment
PremiumCompany Announcements
Revolution Medicines Advances Phase 3 Trial for Pancreatic Cancer Treatment
12d ago
RVMD
Revolution Medicines and Tango Therapeutics Advance in Targeted Cancer Therapy Study
PremiumCompany Announcements
Revolution Medicines and Tango Therapeutics Advance in Targeted Cancer Therapy Study
12d ago
RVMD
TNGX
Revolution Medicines Advances Study on KRAS G12D-Mutant Tumors
PremiumCompany Announcements
Revolution Medicines Advances Study on KRAS G12D-Mutant Tumors
12d ago
RVMD
Revolution Medicines Advances KRAS G12C Mutant Tumor Study with RMC-6291 and RMC-6236
PremiumCompany AnnouncementsRevolution Medicines Advances KRAS G12C Mutant Tumor Study with RMC-6291 and RMC-6236
12d ago
RVMD
Revolution Medicines’ RMC-6236: A Promising Study in Advanced Solid Tumors
Premium
Company Announcements
Revolution Medicines’ RMC-6236: A Promising Study in Advanced Solid Tumors
12d ago
RVMD
Revolution Medicines announces U.S. FDA granted ODD to daraxonrasib
Premium
The Fly
Revolution Medicines announces U.S. FDA granted ODD to daraxonrasib
12d ago
RVMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >